Entrada Therapeutics grants 61,365 RSUs, 19,425 stock options to new hires under inducement plan

Entrada Therapeutics granted 61,365 RSUs and options for 19,425 shares to eight newly hired non-executive employees under its 2025 Inducement Equity Plan.

The options carry an exercise price of $7.07 per share, set at the Aug. 31 closing price.

Option vesting: 25% after one year, with the remaining 75% vesting in equal monthly installments, fully vested by year four.

RSU vesting: 25% after one year, then 6.25% quarterly, subject to continued service.